FDA Inspection 1230448 — Xttrium Laboratories, Inc.
The FDA completed an inspection of Xttrium Laboratories, Inc. on February 6, 2024 in Mount Prospect, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 6, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Mount Prospect, IL (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)